NL-OMON36669撤回2 期
Ibritumomab followed by a reduced intensity, partial T cell-depleted allogeneic stem cell transplantation and immunomodulation with lenalidomide and DLI in patients with relapsed diffuse large B-cell Non-Hodgkins lymphoma - allogeneic stem cell transplantation followed by immunotherapy in DLBC
niversitair Medisch Centrum Utrecht0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •By histology confirmed CD20+ DLBCL de novo, relapsed after autologous stem cell transplantation
- •At least partial response according to the Cheson criteria, before entering the protocol, by the use of a salvage chemotherapy regimen
- •age 18-65 years
排除标准
- •previous diagnosis of follicular lymphoma
- •primary cerebral lymphoma or cerebral localisation
研究者
相似试验
进行中（未招募）
1 期
Imiquimod therapy after surgical removal of anal HPV-lesions to reduce likelihood of recurrenceEUCTR2017-000842-23-ATMedical University Innsbruck200
尚未招募
2 期
Cure rate of childhood B cell lymphoma with rituximab and reduced strength of chemotherapyCTRI/2017/09/009650Cancer Institute adyar
招募中
1 期
DUPI REDUCE trial (DUPIlumab dose REDUCtion in patients with controlled atopic Eczema): a multicenter, low-intervention, non-inferiority randomized controlled trial, embedded in the TREAT NL registry.Atopic eczemaMedDRA version: 21.1Level: LLTClassification code: 10003641Term: Atopic eczema Class: 10040785CTIS2023-504171-24-00Amsterdam UMC216
进行中（未招募）
1 期
Phase II Study of Fractionated 90Y Ibritumomab tiuxetan (ZevalinTM) as initial therapy of Follicular Lymphoma - FIZZ StudyFollicular lymphoma LLT Follicle centre lymphoma, follicular grade I, II, III PT Follicle centre lymphoma, follicular grade I, II, III MedDRA Version 9EUCTR2006-000598-31-GBChristie Hospital NHS Trust80
招募中
2 期
Blinatumomab added to prephase and consolidation therapy in precursor B-acute lymphoblastic leukemia in adults. A phase II trial.acute lymphoblastic leukemiaprecursor B-acute lymphoblastic leukemia10024324NL-OMON50553HOVO65